Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	#o	#f	T	TVal	Price	Qty	oc	Own	H
4/25/25 16:32	4/25/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	11	17	P	2,003	8.18	245	62	642	D
3/27/25 08:13	3/26/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	6	11	P	584	0.5846	999	11	9,923	D
3/19/25 16:38	3/17/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	4	P.d	149	3.73	40	37	149	D
2/11/25 19:00	2/7/25	OCX	Oncocyte Corp	CA	Health	Diagn	In Vitro & In Vivo Diagnostic	5	14	P.dm	24,453	2.38	10,291	64	26,331	D
12/13/24 16:12	12/11/24	QDEL	Quidelortho Corp		Health	Diagn	In Vitro & In Vivo Diagnostic	2	2	P	350	42.72	8	207	12	I
11/12/24 08:01	11/11/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	P	308	26.82	12	40	40	D
10/9/24 13:18	9/6/24	CDIO	Cardio Diagnostics Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	7	P	130	0.2897	448	14	3,565	D
7/16/24 21:13	7/12/24	TKNO	Alpha Teknova, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	4	4	P.m	15,200	1.24	12,227	83	26,972	D
7/11/24 17:15	5/31/24	AWH	Aspira Women'S Health Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	4	P.d	23	0.4895	47	2	1,989	D
3/8/24 11:24	3/6/24	CATX	Perspective Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	P	57,409	0.9500	60,431	107	116,773	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person